It is now generally accepted that allergic respiratory disease has been described as "locking in" the immune response to a particular (polarised) cytokine pattern. 4 in adulthood is associated with active T cell immunity to common inhalant allergens that is skewed towards the Consistent with this general model, it has now been shown that the development of T cell immunity during T helper (Th) 2 cytokine phenotype, in contrast to the expression of Th1 skewed immunity in non-responsive chronic exposure of rats and mice to passively inhaled and ingested allergens is regulated by a comparable set of normal subjects.
1 2 The question of how these two different patterns of T cell immunity develop in individuals is thereimmune deviation mechanisms, and that the key cytokinemediated events which control the selection of relevant Th fore central to our understanding of the aetiology of diseases such as atopic asthma and rhinitis and is the subject of memory cells occur during the early phase of allergen exposure. [5] [6] [7] intensive investigation. The studies in experimental animals which originally In relation to the aetiology of human allergic disease, these findings serve to focus attention on the life phase described T helper 1 and 2 subtypes demonstrated that they operated in a yin-yang fashion during systemic immune during which environmental allergens are first encountered -that is, the perinatal period. There is now a wide body responses via the production of mutually antagonistic cytokines and, further, that the nature of the long term imof evidence that initial priming of the T cell system to these allergens commonly occurs during late gestation (fig munity that subsequently developed was dependent upon the cytokine phenotype of the Th cells that eventually 1). [7] [8] [9] In the case of inhalants, this is followed postnatally by a period of Th cell selection in response to repeated achieved dominance in the specific T cell memory compartment.
3 This Th cell dominance is reinforced at each exposure to environmental allergen involving crossregulation between competing Th1 and Th2 cells. In most subsequent re-exposure to the antigen, a process which group.bmj.com on June 23, 2017 -Published by http://thorax.bmj.com/ Downloaded from subjects this process results in the development of Th1 Th2 20 which is apparently an evolutionary adaptation for protection of the fetoplacental unit against the toxic effects skewed immunity, but in a significant subset of children the initial expression of allergen-specific immunity is polarised of Th1 cytokines such as IFN . 21 This may underlie the epidemiological findings suggestive On the basis of a wide body of epidemiological evidence from cross sectional studies, [11] [12] [13] [14] these persistent Th2 reof a "protective" role for infections during childhood in the aetiology of allergic disease 8 25-27 via mechanisms such sponders constitute the high risk group for subsequent development of severe bronchial hyperreactivity which, in as bystander stimulation of Th1 selective cytokine pathways during host antimicrobial responses.
2 a significant proportion, will progressively worsen into adulthood resulting in chronic asthma. However, it may It may be possible in the future to reproduce the immunostimulatory effects of normal postnatal microbial again be inferred from cross sectional studies demonstrating age related declines in both Th2 dependent IgE exposure via the use of appropriate Th1 selective adjuvants which are under development in a number of centres, and production and skin prick test (SPT) reactivity 15 and also in bronchial hyperresponsiveness 16 that the capacity for if successful they may prove useful in high risk subgroups in which objective evidence of sluggish T cell function can "self healing" in this process is preserved beyond the stage at which severe atopic respiratory disease develops.
be identified. The potential pitfalls of such an approach are excessive amplification of Th1 immunity leading to Treatment of established disease is currently based on blocking the effector arm of the inflammatory cascade at allergen specific delayed type hypersensitivity and stimulation of covert Th1 mediated disease processes including sites of allergen induced tissue damage, or on immunotherapeutic inhibition of upstream Th cell immunity which autoimmunity; both possibilities could be pretested in appropriate animal models. is believed to provide the principal drive for both the induction and maintenance of atopic disease. In principle, this involves preferential stimulation of Th1 selection mechanisms 17 which are presumably analogous to those -  This suggested approach which has been described in detail which dominate Th1/Th2 switch regulation in allergenspecific immune responses in normal (non-atopic) infants. previously 7 28 involves enhancing the efficiency of normal Th1 selection in early immune responses to inhalant The success of these treatments is highly variable, especially in chronic disease. Additionally, it is apparent that allergens. It is based on observations which indicate that low level allergen specific IgE titres in individual children the prevalence of allergic respiratory disease, particularly atopic asthma, is progressively increasing and there is, typically seesaw for several years before either disappearing permanently (development of dominant Th1 immunity) accordingly, growing interest in prevention of this disease through early intervention during childhood. The disor progressing into the responder range (dominant Th2 immunity). This latter period of Th1/Th2 crossregulation cussion below focuses upon the growing list of potential intervention strategies which are illustrated in fig 1 and preceding the development of dominance by either Th cell type theoretically provides a "window" for immunothe theoretical basis underlying each approach.
prophylaxis -that is, for tipping the balance towards selection of protective Th1 immunity. One possibility may be to exploit the consistent findings Potential intervention strategies       that repeated exposure of the upper respiratory or gastrointestinal mucosae to microgram levels of protein antigen As noted above, transplacental priming of the T cell system against environmental allergens appears relatively comleads to the preferential suppression of Th2 dependent IgE production via immune deviation. 7 Both intranasal and mon 7-9 and it has been proposed that, in neonates genetically at high risk for atopy, this process may be oral allergen exposure have previously been employed for immunotherapy in established allergic disease with mixed intrinsically skewed away from the Th1 phenotype. 18 This proposal is based upon a preliminary study on in vitro T success, but the evidence from experimental systems argues that they are likely to be considerably more successful cell responses to food allergens such as -lactoglobulin which is present in relatively high concentrations in the when applied earlier in the immune response -that is, before Th2 memory becomes consolidated. maternal circulation. The more complex questions relating to the significance of potential transplacental transfer of
In principle, such a procedure would employ a mixture comprising the 3-4 dominant inhalant allergens from a inhalant allergens to which the mother is exposed have not been addressed. particular environment. The main issue to be resolved in this context is whether such a regime has the potential for overstimulation of Th1 immunity (resulting in delayed type hypersensitivity) or whether it may amplify covert        There is now evidence from a series of independent laboratTh2 responses in some subjects. It is also important to note that such procedures could not be employed in early ories 8 that maturation of the capacity to produce Th1 cytokines such as interferon gamma (IFN ) is delayed in infancy when the risk of development of Th2 skewed immunity is maximal. children genetically at risk for development of atopic disease, and it has been proposed that this may be an aetiological factor in primary allergic sensitisation. 19 This initial skewing of the immune system towards the Th2         phenotype may be a subtle distortion of a normal process which is operative in all neonates. This surmise is based
There is convincing epidemiological evidence that exposure to high levels of inhalant allergens during the first three on recent evidence that the immunological milieu at the fetal/maternal interface is constitutively skewed towards months of life predisposes to primary allergic sensitisation group.bmj.com on June 23, 2017 -Published by http://thorax.bmj.com/ Downloaded from and thus to the acquisition of long term Th2 as opposed that there is currently very little information available on the potential immunological side effects of these drugs in to Th1 dependent immunity, 29 and this presumably derives from the intrinsic skewing of perinatal Th cell function young children, particularly on Th1/Th2 switch regulation. In this context, there is now evidence that systemic and described above. As noted earlier, 7 29 mucosal allergen exposure of newborn experimental animals also fails to inhaled steroids exert marked effects on the turnover of the dendritic cell network in the airway epithelium.
33 34
tolerise IgE responses. Thus, in principle, measures to minimise levels of inhalant allergens in the nursery are These dendritic cells regulate the presentation of inhaled allergen to the T cell system, particularly during the early likely to be beneficial.
This question may prove to be more complex than stages of immune responses, and consequently any steroidmediated changes in their functions may have significant expected in view of the fact that, as illustrated in fig 1, the process of Th1/Th2 switch regulation which normally leads (and as yet undefined) effects on the development of allergen-specific Th cell memory. Questions have also been to the development and consolidation of protective Th1 immunity is itself an antigen (allergen)-driven process. In raised in relation to the potential effects of inhaled steroids on lung growth in this age range. this context, recent studies have demonstrated house dust mite-specific T cell reactivity in the majority of Swedish Another candidate may be the cromolyns which have been used for many years in paediatric practice with little children from an environment where levels of house dust mite were 10-100 times lower than the threshold associated evidence of side effects. However, recent information demonstrating inhibition of aspects of B cell function including with expression of house dust mite mediated allergic respiratory disease.
27 30 This suggests nonetheless that sucIgE production 35 suggest that their safe usage in this context may require close monitoring of allergen-specific Th cell cessful Th1 selection can occur at "safe" levels of allergen exposure.
activity in order to demonstrate that any improvement in IgE titres and/or SPT reactivity during treatment is not accompanied by covert increases in Th2 memory which could be read out later by the B cell system after withdrawal        of the drug. The inverse relationship between age and IgE titres/SPT reactivity/bronchial hyperresponsiveness 15 16 indicates that Th2 skewed allergen-specific immunity acquired in childConclusion hood is in many cases reversible with continuing allergen
The information now available on the aetiology and pathoexposure. However, a significant subset of subjects instead genesis of atopic respiratory disease, while incomplete, has consolidate their Th2 reactivity with age and become reached the stage where informed debate on potential represented in the group with chronic airways hyperprimary prevention strategies can be carried out. It is responsiveness. The nature of the factor(s) which deterimperative that relevant ethical issues remain paramount mine whether an individual's inhalant allergen-specific T in these discussions, as inappropriate interference in the cell reactivity reverses or progresses to ultimate expression development of allergen-specific immunological memory of allergen induced bronchial hyperresponsiveness remains during childhood may have lifelong consequences. Neverone of the key issues in this area.
theless, the potential that helping the immune system to A widely held view is that the development of bronchial "get it right" early in life may prevent a lifetime of suffering hyperresponsiveness is the end result of sustained tissue is a goal that is worthy of vigorous pursuit. damage and associated remodelling induced by increasingly intense cycles of Th2 dependent cellular inflammation (fig vironmental levels of house dust mite, and isolation of house dust mite reactive subjects into an environment free for primary prevention during childhood.
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